Emily B. Dunkelberger

Also affiliated with National Institute of Diabetes and Digestive and Kidney Diseases

MedicinePhysics and AstronomyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease”.

A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease

Blood(2022)10.1182/blood.2022015403

N/A

2.4DataRank · unranked

74 citations

Anna Conrey, Ingrid Frey, Eveline Gwaabe, Laurel A. Menapace, Laxminath Tumburu +15 more

Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease

Haematologica(2024)10.3324/haematol.2023.284831

N/A

0.538DataRank · unranked

12 citations

Kang Le, Maureen Lundt, Quan Li, Emily B. Dunkelberger, Troy Cellmer +9 more

Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease

Blood Red Cells & Iron(2025)10.1016/j.brci.2025.100014

N/A

0.256DataRank · unranked

4 citations

Nancy Asomaning, Ingrid Frey, Ruth Pierre Charles, Dianna Lovins, Julia Xu +13 more